Pharma Pulse 4/1/25: Addressing Regulatory Challenges with Trial Diversity, Medicaid Cuts Remain Center Stage & more

Addressing Current Regulatory Challenges with Diversity in Clinical Trials

In this video interview, Craig Lipset, co-chair, Decentralized Trials & Research Alliance (DTRA), discusses how the current political climate is affecting diversity in clinical research and how diversity action plans may be impacted.

Medicaid Cuts Remain Center Stage as Experts Address Industry Challenges

In a recent conversation with Jennifer McGuigan Babcock, senior vice president for Medicaid policy at the Association for Community Affiliated Plans (ACAP), and Gabe Scott, a partner at K&L Gates Health Care Group, the two discussed efforts to protect Medicaid’s role in the healthcare system and the consequences of the budget cuts announced in February.

Will US Tariffs Lift the Veil on India’s Drug Safety Problem?

The sector needs to clean up its act and focus on quality. It won’t until New Delhi insists on more and better regulations.

Rite Aid Shares ‘ABCs’ of Allergy Season to Help Nip Symptoms in the Bud

Millions of Americans greet spring’s arrival with itchy eyes, runny noses and sneezing fits. Rite Aid is helping customers manage those persistent allergy symptoms with simple solutions for the whole family before peak season arrives.

The oncology sector faces unique challenges in market access, requiring specialized strategies to ensure commercial success.

Petauri on LinkedIn

In a recent issue of Pharmaceutical Executive, Formulary Insights—Powered by Petauri's Shana Gunderson Hua, PharmD and Nancy Pham delve into the complexities of securing and optimizing market access for oncology therapies and highlight key strategies for overcoming these hurdles, including:
✔️ Earlier and deeper engagement with payers
✔️ Differentiated and robust value stories
✔️ Deep oncology expertise as a necessity
✔️ Enhancing patient support beyond access

🔗 Read the full article here:https://lnkd.in/eQQb_ZTA

As oncology continues to demand a specialized approach, oncology-focused market access expertise is no longer a competitive advantage—it is a necessity. Learn more about how Petauri can support your access goals by visiting us at www.petauri.com

#ThoughtLeadership #Oncology #MarketAccess #Healthcareinnovation

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs